Adding to the list of the many failed studies on Alzheimer’s drugs in recent times – the most recent being vTv Therapeutics’ azeliragon – Eli Lilly Tuesday said it halted two advanced trials on lanabecestat, its experimental formulation for the treatment of the crippling brain disorder that destroys patients’ memory. https://news.alphastreet.com/alzheimers-patients-get-a-fresh-jolt-as-lilly-ends-clinical-trial-prematurely/
More Alz-failure by the faded flower. Same as it ever was. Sidney & jcL laugh from the lowest circle of Hell.
Hundreds of LLY employees tried for years to make this a reality. Innovation takes time, money, brains and guts. What have YOU done recently?